Abstract: Present invention relates to new processes for making Swiss cheeses or Continental cheeses type with an improvement of eyes formation and distribution. This present invention relates the culture design and use of particles with defined properties based on technical knowledges about eyes formation. More specifically the present invention relates to a process for making cheese, the process comprising: a. Obtaining a milk composition b. Optionally maturing said milk composition by physical, chemical or biological means c. Adding particles with a size of 1 ?m to 50 ?m to said milk composition d. Adding lactic acid bacteria and/or proprionic bacteria e. Adding coagulant, wherein steps c, d, and e may be done in random order, sequentially or simultaneously f. and further processing the composition to produce a cheese.
Abstract: The present invention provides novel Lactococcus lactis lactic acid bacterium strains having improved texturing properties and methods of using the strains for producing food products.
Type:
Application
Filed:
August 21, 2020
Publication date:
December 22, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Vera Kuzina POULSEN, Gunnar OEREGAARD, Elahe Ghanei MOGHADAM
Abstract: The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.
Abstract: The present invention relates to a method for drying human milk oligosaccharides (HMOs). More specifically, the present invention is related to a method of roller drying or drum drying of human milk oligosaccharides in a simple and economical way.
Type:
Application
Filed:
November 12, 2020
Publication date:
December 15, 2022
Applicant:
Chr. Hansen HMO GmbH
Inventors:
Stefan Jennewein, Mischa Baier, Tobias Seitz, Markus Helfrich
Abstract: Disclosed are peptides and dimeric peptides exhibiting beta-galactosidase enzyme activity, as well as methods for producing a dairy product using them, and dairy products made by such methods. In some embodiments, the peptides exhibit beta-galactosidase enzyme activity at low and/or high temperatures.
Type:
Grant
Filed:
April 11, 2018
Date of Patent:
December 13, 2022
Assignee:
Chr. Hansen A/S
Inventors:
Hans Raj, Pernille Smith, Thomas Eckhardt, Vojislav Vojinovic, Charlotte Elisabeth Grüner Schöller, Johannes Maarten Van Den Brink
Abstract: The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.
Abstract: The present invention relates to a direct vat set starter culture composition comprising lactic acid bacteria comprising a manganese transporter for fermenting a food product and for inhibiting or delaying growth of fungi in said food product, characterized in that the composition comprises up to 600 ppm of manganese.
Type:
Application
Filed:
October 21, 2020
Publication date:
December 8, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Anisha GOEL, Cecilie Lykke Marvig NIELSEN, Helle Skov GULDAGER, Silja Kej DIEMER, Karen Lise Vestergaard ANDERSEN
Abstract: Use of a caramel colorant derived composition comprising the lower Molecular Weight (MW) solid particles of a caramel color product of Class I (E150a), Class II (E150b), Class III (E150c), Class IV (E150d) or a mixture of these Classes for coloring an edible product.
Type:
Grant
Filed:
November 10, 2016
Date of Patent:
November 29, 2022
Assignee:
CHR. HANSEN NATURAL COLORS A/S
Inventors:
Céline Chanforan, Carine Mané, Eric Jouenne
Abstract: Disclosed is a cereal composition which can be prepared instantly with the addition of a liquid, containing at least one human milk oligosaccharide (HMO), and other components which are necessary for the healthy growth and development of a young 5 individual.
Abstract: The present invention relates to new strains of Bacillus paralicheniformis with improved growth rates and plant growth promoting properties and new strains of Bacillus paralicheniformis with improved growth rates when compared to their parental strains from where they are derived.
Type:
Application
Filed:
August 28, 2020
Publication date:
November 3, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Patricia Dominguez Cuevas, Raquel Azevedo, Karin BJERRE, Iuliana Nita, Rute Neves, Lars Moelbak
Abstract: The present invention relates to mutants of lactic acid bacteria which are resistant to the antibiotic ampicillin and which were found to give an increased texture when grown in milk while maintaining the other growth properties of the parent strain. The present invention, furthermore, relates to compositions comprising such mutants, and to dairy products fermented with the lactic acid bacteria resistant to ampicillin.
Type:
Grant
Filed:
June 3, 2019
Date of Patent:
November 1, 2022
Assignee:
Chr. Hansen A/S
Inventors:
Eric Johansen, Kim Ib Soerensen, Annette Kibenich
Abstract: A method for producing a fermented milk product (e.g. a yogurt) with a relatively high stable pH value at the end of the fermentation comprising inoculating milk with Streptococcus thermophilus (ST) Gal(+) bacteria.
Type:
Application
Filed:
June 19, 2020
Publication date:
October 6, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Thomas JANZEN, Ditte Ellegaard CHRISTIANSEN
Abstract: Process for producing an ambient storage food product comprising providing a food product with a pH of between 3.4 and 4.4, subjecting the food product to a heat treatment to obtain a heat treated food product, adding aseptically to the heat treated food product one or more of ambient storage lactic acid bacteria strains to obtain an ambient storage food product, and storing the ambient storage food product at ambient temperature for a period of time, wherein the ambient storage lactic acid bacteria strain is selected from the group consisting of strains: (i) wherein the strain is capable of retaining viability at the end of 20 days at a temperature of 25 #C; and (ii) wherein the pH at most decreases 0.8 units during the storage period; and (iii) wherein the strain is selected from the group consisting of strains of the genus Oenococcus, and mutants thereof.
Type:
Application
Filed:
September 11, 2020
Publication date:
September 29, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Christian GILLELADEN, Victoria PREBNER, Kim Ib SOERENSEN
Abstract: The present invention relates to new improved methods for expressing native lactases in their native hosts. Methods for homologous as well as heterologous expression of lactase in lactic acid bacteria with altered expression dynamics are comprised by present invention.
Type:
Application
Filed:
August 27, 2020
Publication date:
September 29, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Hans RAJ, Charlotte Elisabeth Grüner SCHÖLLER, Kim Ib SOERENSEN, Johannes Maarten VAN DEN BRINK, Ahmad ZEIDAN, Martin Holm RAU, Paula GASPAR, George Nabin BAROI
Abstract: The Lactobacillus curvatus strain deposited as DSM18775 is used as a biopreservative culture in a wide range of meat products due to its production of bacteriocin. The present invention relates to Lactobacillus curvatus strains having an extended lag phase of at least 24 hours at 30° C. relative to DSM18775. In a presently preferred embodiment, the strains are mutants of DSM18775, such as the Lactobacillus curvatus strain deposited as DSM32590 and the Lactobacillus curvatus strain deposited as DSM 32591. Further, the invention relates to a method for inhibiting Listeria in a food product comprising adding bacteria of a Lactobacillus curvatus strain according to the invention to a food product in a concentration of at least 105 CFU/g.
Type:
Grant
Filed:
August 29, 2018
Date of Patent:
September 27, 2022
Assignee:
CHR. HANSEN A/S
Inventors:
Per Stroeman, Christian Elmshaeuser, Kim Ib Soerensen, Tim Martin Seibert, Rute Neves
Abstract: The present invention relates to a method for quantifying the inhibition capacity of at least one, potentially inhibiting, first bacterial or yeast strain towards a gas producing, potentially undesirable, second bacterial or yeast strain, based on a measure of the total gas production. Examples of a first bacterial or yeast strain are probiotic bacterial strains of the genus Bacillus, Lactobacillus or Lactococcus, and examples of the gas producing bacterial or yeast strain are bacteria such as Clostridium, fusobacteria, Escherichia coli and Salmonella or yeast such as Saccharomyces or Pichia.
Type:
Application
Filed:
August 6, 2020
Publication date:
September 15, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Giuseppe COPANI, Line SKJOET-RASMUSSEN, Nina MILORA, Audrey SEGURA
Abstract: The present invention provides novel Lactococcus lactis lactic acid bacterium strains having improved texturing properties and methods of using the strains for producing food products.
Type:
Application
Filed:
August 21, 2020
Publication date:
September 15, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Vera Kuzina POULSEN, Gunnar OEREGAARD, Elahe Ghanei MOGHADAM
Abstract: Disclosed are non-sporulating Bacillus cells for the production of a sialylated oligosaccharide wherein said Bacillus cell has been genetically engineered to possess a lactose permease, a CMP-NeuNAc biosynthesis pathway and a sialyltransferase, as well as a method for producing a sialylated oligosaccharide using said Bacillus cell.
Type:
Application
Filed:
August 10, 2020
Publication date:
September 15, 2022
Applicant:
Chr. Hansen HMO GmbH
Inventors:
Stefan Jennewein, Dirk Wartenberg, Stefanie Habersetzer
Abstract: The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.
Abstract: Present invention relates to new strains of Bacillus paralicheniformis with improved ability to form biofilm and colonize the rhizosphere when compared to their parental strains from where they are derived.
Type:
Application
Filed:
May 28, 2020
Publication date:
August 25, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Patricia Dominguez CUEVAS, Rute NEVES, Raquel AZEVEDO, Lars MOELBAK, Lorenzo FIMOGNARI